Novel Therapies for Type 2 Diabetes
Highlighting new drug classes, such as SGLT-2 inhibitors and GLP-1 receptor agonists, and their impact on glucose control and cardiovascular outcomes. Several novel therapies have emerged in recent years for the treatment of type 2 diabetes. These therapies offer alternative mechanisms of action, improved efficacy, and reduced side effects compared to traditional treatment options.
- Glucose-Lowering Medications
- Personalized Medicine Approaches
- Bariatric Surgery and Metabolic Interventions
- Gut Microbiota and Probiotics
- Regenerative Medicine and Stem Cell Therapies
Related Conference of Novel Therapies for Type 2 Diabetes
September 23-24, 2026
24th Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
September 28-29, 2026
25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Berlin, Germany
November 23-24, 2026
35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Amsterdam, Netherlands